Overview

Pharmacokinetics of Advantage Arrest in Children

Status:
Completed

Trial end date:
2020-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to characterize basic PK parameters (Cmax, t1/2, AUC) in healthy children to contribute to evidence for the safety of Advantage Arrest, consistent with Guidance for Industry--Exposure--Response Relationships (April 2003).

Phase:

Phase 2

Details

Lead Sponsor:

Advantage Silver Dental Arrest, LLC

Collaborator:

University of California, San Francisco

Treatments:

Fluorides
Imidacloprid